First described in a paper published 4 years ago, the new Gleason grade group system for the risk classification of prostate cancer (PCa) is now routinely included in PCa pathology reports and commonly used in counseling patients newly diagnosed with the malignancy. Read more read more →

LOWELL — Week after week, the man battling prostate cancer visits the hospital for conventional radiation therapy. The grueling, marathon treatment plan stretches for more than two months. Read more read more →

Although about 1 in 7 men will be eventually be diagnosed with prostate cancer in his lifetime, the warning signs of the disease are often vague and may be confused with other conditions, experts at Fox Chase Cancer Center say. Read more read more →

Andrew J. Armstrong, MD, associate professor of medicine and surgery, Department of Medicine, Duke University School of Medicine, discusses precision medicine for patients with metastatic prostate cancer. Read more read more →

“I’ve never understood why men don’t talk about it. A couple of men I know who had prostate cancer, as far as them coming together — nobody talks about it. There are times men are bragging, you know, on this subject, but now it’s just total silence,” says “Joe” (not his real name) of Oxnard,.. read more →